Indraprastha Medical Corp Reports Robust Q1 Performance with 15% Net Profit Growth
Indraprastha Medical Corporation Limited, operating as Indraprastha Apollo Hospitals, announced robust Q1 results. EBITDA increased to ₹726.00 million from ₹680.00 million year-over-year, with EBITDA margin rising to 19.89%. Net profit grew by 15% to ₹515.00 million, and revenue rose to ₹3.70 billion. The company reported a 4.94% increase in revenue from operations and a 14.94% increase in profit after tax. The Board of Directors made key corporate governance decisions, including new appointments and scheduling the 37th Annual General Meeting.
16May 25
Indraprastha Medical Corp Reports Strong Q4 Results, Declares Dividend
Indraprastha Medical Corp announced impressive Q4 financial results with EBITDA rising to ₹615.00 million from ₹484.00 million year-over-year. Net profit increased to ₹410.00 million, up 31.41% YoY. Revenue grew by 5.10% to ₹3.30 billion. The company declared a dividend of ₹4.50 per equity share. Annual performance showed significant growth with revenue up 13.79%, EBITDA up 30.80%, and net profit up 44.02% YoY. EPS increased from ₹9.40 to ₹13.52, and operating profit margin improved to 15.53% from 13.72%.